TrialFind
Saved trials
Back to results
Completed
Phase 2
A Study of 3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients.
NCT06849843
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Nanjing First Hospital
Nanjing, Jiangsu, China
+9 additional locations
View on ClinicalTrials.gov
Official details
A Study of 3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients. — TrialFind